181 related articles for article (PubMed ID: 22554803)
1. Augmentation of reduced folate carrier-mediated folate/antifolate transport through an antiport mechanism with 5-aminoimidazole-4-carboxamide riboside monophosphate.
Visentin M; Zhao R; Goldman ID
Mol Pharmacol; 2012 Aug; 82(2):209-16. PubMed ID: 22554803
[TBL] [Abstract][Full Text] [Related]
2. 5-amino-4-imidazolecarboxamide riboside potentiates both transport of reduced folates and antifolates by the human reduced folate carrier and their subsequent metabolism.
McGuire JJ; Haile WH; Yeh CC
Cancer Res; 2006 Apr; 66(7):3836-44. PubMed ID: 16585211
[TBL] [Abstract][Full Text] [Related]
3. 5-aminoimidazole-4-carboxamide riboside enhances effect of ionizing radiation in PC3 prostate cancer cells.
Isebaert SF; Swinnen JV; McBride WH; Begg AC; Haustermans KM
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1515-23. PubMed ID: 21944462
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate reduces HbA1c concentration but does not produce chronic accumulation of ZMP in patients with rheumatoid or psoriatic arthritis.
Perdan-Pirkmajer K; Pirkmajer S; Thevis M; Thomas A; Praprotnik S; Hočevar A; Rotar Ž; Gašperšič N; Sodin-Šemrl S; Žibert J; Omersel J; Chibalin AV; Tomšič M; Ambrožič A
Scand J Rheumatol; 2016 Oct; 45(5):347-55. PubMed ID: 26726793
[TBL] [Abstract][Full Text] [Related]
5. Low-dose methotrexate results in the selective accumulation of aminoimidazole carboxamide ribotide in an erythroblastoid cell line.
Funk RS; van Haandel L; Becker ML; Leeder JS
J Pharmacol Exp Ther; 2013 Oct; 347(1):154-63. PubMed ID: 23887097
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of 5-aminoimidazole-4-carboxamide ribotide transformylase, adenosine deaminase and 5'-adenylate deaminase by polyglutamates of methotrexate and oxidized folates and by 5-aminoimidazole-4-carboxamide riboside and ribotide.
Baggott JE; Vaughn WH; Hudson BB
Biochem J; 1986 May; 236(1):193-200. PubMed ID: 2431676
[TBL] [Abstract][Full Text] [Related]
7. 5-Aminoimidazole-4-carboxamide 1-beta -D-ribofuranoside (AICAR) stimulates myocardial glycogenolysis by allosteric mechanisms.
Longnus SL; Wambolt RB; Parsons HL; Brownsey RW; Allard MF
Am J Physiol Regul Integr Comp Physiol; 2003 Apr; 284(4):R936-44. PubMed ID: 12626360
[TBL] [Abstract][Full Text] [Related]
8. Regulation of carrier-mediated transport of folates and antifolates in methotrexate-sensitive and-resistant leukemia cells.
Jansen G; Mauritz RM; Assaraf YG; Sprecher H; Drori S; Kathmann I; Westerhof GR; Priest DG; Bunni M; Pinedo HM; Schornagel JH; Peters GJ
Adv Enzyme Regul; 1997; 37():59-76. PubMed ID: 9381986
[TBL] [Abstract][Full Text] [Related]
9. Metabolic preconditioning of cells with AICAR-riboside: improved cryopreservation and cell-type specific impacts on energetics and proliferation.
Menze MA; Chakraborty N; Clavenna M; Banerjee M; Liu XH; Toner M; Hand SC
Cryobiology; 2010 Aug; 61(1):79-88. PubMed ID: 20510224
[TBL] [Abstract][Full Text] [Related]
10. 5-Aminoimidazole-4-carboxyamide-ribonucleoside (AICAR)-stimulated hepatic expression of Cyp4a10, Cyp4a14, Cyp4a31, and other peroxisome proliferator-activated receptor α-responsive mouse genes is AICAR 5'-monophosphate-dependent and AMP-activated protein kinase-independent.
Bumpus NN; Johnson EF
J Pharmacol Exp Ther; 2011 Dec; 339(3):886-95. PubMed ID: 21896918
[TBL] [Abstract][Full Text] [Related]
11. Role of purine biosynthetic intermediates in response to folate stress in Escherichia coli.
Rohlman CE; Matthews RG
J Bacteriol; 1990 Dec; 172(12):7200-10. PubMed ID: 2254281
[TBL] [Abstract][Full Text] [Related]
12. Therapeutics by cytotoxic metabolite accumulation: pemetrexed causes ZMP accumulation, AMPK activation, and mammalian target of rapamycin inhibition.
Racanelli AC; Rothbart SB; Heyer CL; Moran RG
Cancer Res; 2009 Jul; 69(13):5467-74. PubMed ID: 19549896
[TBL] [Abstract][Full Text] [Related]
13. AICAR promotes endothelium-independent vasorelaxation by activating AMP-activated protein kinase via increased ZMP and decreased ATP/ADP ratio in aortic smooth muscle.
Pyla R; Hartney TJ; Segar L
J Basic Clin Physiol Pharmacol; 2022 Nov; 33(6):759-768. PubMed ID: 35503763
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of hepatocytic autophagy by adenosine, aminoimidazole-4-carboxamide riboside, and N6-mercaptopurine riboside. Evidence for involvement of amp-activated protein kinase.
Samari HR; Seglen PO
J Biol Chem; 1998 Sep; 273(37):23758-63. PubMed ID: 9726984
[TBL] [Abstract][Full Text] [Related]
15. Folate transporter dynamics and therapy with classic and tumor-targeted antifolates.
O'Connor C; Wallace-Povirk A; Ning C; Frühauf J; Tong N; Gangjee A; Matherly LH; Hou Z
Sci Rep; 2021 Mar; 11(1):6389. PubMed ID: 33737637
[TBL] [Abstract][Full Text] [Related]
16. Metabolomics and proteomics identify the toxic form and the associated cellular binding targets of the anti-proliferative drug AICAR.
Douillet DC; Pinson B; Ceschin J; Hürlimann HC; Saint-Marc C; Laporte D; Claverol S; Konrad M; Bonneu M; Daignan-Fornier B
J Biol Chem; 2019 Jan; 294(3):805-815. PubMed ID: 30478173
[TBL] [Abstract][Full Text] [Related]
17. The major facilitative folate transporters solute carrier 19A1 and solute carrier 46A1: biology and role in antifolate chemotherapy of cancer.
Matherly LH; Wilson MR; Hou Z
Drug Metab Dispos; 2014 Apr; 42(4):632-49. PubMed ID: 24396145
[TBL] [Abstract][Full Text] [Related]
18. Purine biosynthesis in the domain Archaea without folates or modified folates.
White RH
J Bacteriol; 1997 May; 179(10):3374-7. PubMed ID: 9150241
[TBL] [Abstract][Full Text] [Related]
19. Relationship between 5-aminoimidazole-4-carboxamide-ribotide and AMP-activated protein kinase activity in the perfused mouse heart.
Zhang L; Frederich M; He H; Balschi JA
Am J Physiol Heart Circ Physiol; 2006 Mar; 290(3):H1235-43. PubMed ID: 16258030
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate enhances the antianabolic and antiproliferative effects of 5-aminoimidazole-4-carboxamide riboside.
Beckers A; Organe S; Timmermans L; Vanderhoydonc F; Deboel L; Derua R; Waelkens E; Brusselmans K; Verhoeven G; Swinnen JV
Mol Cancer Ther; 2006 Sep; 5(9):2211-7. PubMed ID: 16985054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
